Loading
Latest filing published 23 Jul 2026 for CG인바이츠. Read the official filing
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
인바이츠바이오코아 (chief executive) discloses dealings in CG인바이츠 to DART (FSS). Between 24 October 2024 and 23 July 2026, the trades on record add up to 7 filings.
Purchases make up the whole of the open-market record (7 purchases, €188k). The amount is not disclosed for 6 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2026 alone, the filings show 3 purchases and no sales.
The latest filing, published on 23 July 2026, reports an open-market purchase in CG인바이츠. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations